GSK3B and neoplasm: GSK3β protein expression was increased in 14/29 (48%) of tumours (at p<0.05; Kruskal-Wallis test) when compared to the patient-matched normal tissue, decreased in 3/29 (10%) tumours (p<0.05) and unchanged in the remaining 12 tumours (i.e. p>0.05).